KYMR
KYMR
US5015751044
Kymera Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
9.35B EUR
9.49B EUR
6.84B EUR
6.33B EUR
Enterprise Value
8.48B EUR
9.45B EUR
6.78B EUR
6.05B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-22.05x
--
--
--
Price to Sales
89.01x
90.41x
132.98x
369.83x
Price to Book
6.17x
6.29x
4.45x
4.01x
EV/Revenue
80.72x
89.98x
131.74x
353.77x
EV/EBITDA
-24.94x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.54%
-2.51%
-3.56%
-2.45%
ende